Fredun Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

349.07

274.34

221.74

131.55

110.30

Operating profit

38.90

27.44

11.07

6.80

5.80

Interest

13.65

9.28

4.67

4.16

4.41

Gross profit

25.25

20.32

10.76

6.37

4.37

EPS (Rs)

33.25

23.84

14.29

5.05

4.77

Other income

-

2.16

4.35

3.74

2.99

Stock adjustment

-22.44

-37.72

-0.01

1.17

-5.04

Raw material

283.76

245.57

176.45

100.60

85.18

Power and fuel

-

-

-

-

-

Employee expenses

12.50

11.53

10.66

8.66

8.95

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

36.35

27.52

23.56

14.33

15.41

Provisions made

-

-

-

-

-

Depreciation

3.80

2.81

2.16

2.00

1.88

Taxation

5.83

6.70

2.26

1.19

0.59

Net profit / loss

15.62

10.81

6.34

2.01

1.90

Extra ordinary item

-

-

-

-1.16

-

Prior year adjustments

-

-

-

-

-

Equity capital

4.70

4.53

4.43

3.99

3.99

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.14

10.00

4.99

5.17

5.26

GPM (%)

-

7.35

4.76

4.71

3.86

NPM (%)

-

3.91

2.80

1.49

1.68